ID: ALA4163792

Max Phase: Preclinical

Molecular Formula: C27H19N3O3S

Molecular Weight: 465.53

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C1/C(=N\C(=S)NCc2cc3ccccc3cc2O)c2ccccc2N1C(=O)c1ccccc1

Standard InChI:  InChI=1S/C27H19N3O3S/c31-23-15-19-11-5-4-10-18(19)14-20(23)16-28-27(34)29-24-21-12-6-7-13-22(21)30(26(24)33)25(32)17-8-2-1-3-9-17/h1-15,31H,16H2,(H,28,34)/b29-24-

Standard InChI Key:  HANSKDOIKKLXTL-OLFWJLLRSA-N

Associated Targets(Human)

Blood (2950 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF10 (107 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACE Tclin Angiotensin-converting enzyme (1423 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

DNA (609 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 465.53Molecular Weight (Monoisotopic): 465.1147AlogP: 4.60#Rotatable Bonds: 3
Polar Surface Area: 82.00Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.00CX Basic pKa: CX LogP: 5.17CX LogD: 5.16
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.34Np Likeness Score: -0.68

References

1. Manikandan A, Moharil P, Sathishkumar M, Muñoz-Garay C, Sivakumar A..  (2017)  Therapeutic investigations of novel indoxyl-based indolines: A drug target validation and Structure-Activity Relationship of angiotensin-converting enzyme inhibitors with cardiovascular regulation and thrombolytic potential.,  141  [PMID:29032034] [10.1016/j.ejmech.2017.09.076]

Source